1.0Public Citizenhttps://www.citizen.orgDiane Krauthamerhttps://www.citizen.org/author/dkrauthamer/Public Citizen Statement to the FDA on Pharmacy Compounding Issues Related to Use of Bulk Substances and Office Stock - Public Citizenrich600338<blockquote class="wp-embedded-content" data-secret="zp2e2fTIhy"><a href="https://www.citizen.org/article/public-citizen-statement-to-the-fda-on-pharmacy-compounding-issues-related-to-use-of-bulk-substances-and-office-stock/">Public Citizen Statement to the FDA on Pharmacy Compounding Issues Related to Use of Bulk Substances and Office Stock</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.citizen.org/article/public-citizen-statement-to-the-fda-on-pharmacy-compounding-issues-related-to-use-of-bulk-substances-and-office-stock/embed/#?secret=zp2e2fTIhy" width="600" height="338" title="“Public Citizen Statement to the FDA on Pharmacy Compounding Issues Related to Use of Bulk Substances and Office Stock” — Public Citizen" data-secret="zp2e2fTIhy" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]> */
</script>
In a statement to Food and Drug Administration (FDA) officials during a listening session with consumer groups, Public Citizen urged the FDA to prevent compounding using bulk drug substances that have been identified as unsafe or ineffective by FDA reviewers. We also expressed strong support for the FDA’s proposal to prevent compounding pharmacies from engaging in compounding large quantities of products for sale to healthcare providers as office stock.https://www.citizen.org/wp-content/uploads/public_citizen_shared_link.jpg1200628